These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 31522319)

  • 21. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
    Cohen S; Cannon GW; Schiff M; Weaver A; Fox R; Olsen N; Furst D; Sharp J; Moreland L; Caldwell J; Kaine J; Strand V
    Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methotrexate-related minor adverse effects in rheumatoid arthritis: more than a nuisance.
    Dhir V; Aggarwal A
    J Clin Rheumatol; 2012 Jan; 18(1):44-6. PubMed ID: 22157277
    [No Abstract]   [Full Text] [Related]  

  • 23. Prediction of methotrexate intolerance in juvenile idiopathic arthritis: a prospective, observational cohort study.
    van Dijkhuizen EH; Bulatović Ćalasan M; Pluijm SM; de Rotte MC; Vastert SJ; Kamphuis S; de Jonge R; Wulffraat NM
    Pediatr Rheumatol Online J; 2015; 13():5. PubMed ID: 25745368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic polymorphisms in key methotrexate pathway genes are associated with response to treatment in rheumatoid arthritis patients.
    Owen SA; Hider SL; Martin P; Bruce IN; Barton A; Thomson W
    Pharmacogenomics J; 2013 Jun; 13(3):227-34. PubMed ID: 22450926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Homocysteine and folate status in methotrexate-treated patients with rheumatoid arthritis.
    van Ede AE; Laan RF; Blom HJ; Boers GH; Haagsma CJ; Thomas CM; De Boo TM; van de Putte LB
    Rheumatology (Oxford); 2002 Jun; 41(6):658-65. PubMed ID: 12048292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation of a clinical pharmacogenetic model to predict methotrexate nonresponse in rheumatoid arthritis patients.
    Eektimmerman F; Allaart CF; Hazes JM; Madhar MB; den Broeder AA; Fransen J; Swen JJ; Guchelaar HJ
    Pharmacogenomics; 2019 Jan; 20(2):85-93. PubMed ID: 30628539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The safety of weekly low dose oral methotrexate in an Oriental population with rheumatoid arthritis.
    Thumboo J; Koh WH; Leong KH; Boey ML; Feng PH
    Ann Acad Med Singap; 1997 Mar; 26(2):205-9. PubMed ID: 9208075
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors associated with toxicity, final dose, and efficacy of methotrexate in patients with rheumatoid arthritis.
    Hoekstra M; van Ede AE; Haagsma CJ; van de Laar MA; Huizinga TW; Kruijsen MW; Laan RF
    Ann Rheum Dis; 2003 May; 62(5):423-6. PubMed ID: 12695153
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ATIC 347C>G gene polymorphism may be associated with methotrexate-induced adverse events in south Indian Tamil rheumatoid arthritis.
    Muralidharan N; Mariaselvam CM; Jain VK; Gulati R; Negi VS
    Pharmacogenomics; 2016 Feb; 17(3):241-8. PubMed ID: 26799664
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Associations between single-nucleotide polymorphisms of RFC-1, GGH, MTHFR , TYMS, and TCII genes and the efficacy and toxicity of methotrexate treatment in patients with rheumatoid arthritis.
    Świerkot J; Ślęzak R; Karpiński P; Pawłowska J; Noga L; Szechiński J; Wiland P
    Pol Arch Med Wewn; 2015; 125(3):152-61. PubMed ID: 25599563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between cumulative methotrexate dose, non-invasive scoring system and hepatic fibrosis detected by Fibroscan in rheumatoid arthritis patients receiving methotrexate.
    Lertnawapan R; Chonprasertsuk S; Siramolpiwat S
    Int J Rheum Dis; 2019 Feb; 22(2):214-221. PubMed ID: 30565876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of folylpolyglutamyl synthetase predicts poor response to methotrexate therapy in patients with rheumatoid arthritis.
    Stranzl T; Wolf J; Leeb BF; Smolen JS; Pirker R; Filipits M
    Clin Exp Rheumatol; 2003; 21(1):27-32. PubMed ID: 12673886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene-gene interactions in folate and adenosine biosynthesis pathways affect methotrexate efficacy and tolerability in rheumatoid arthritis.
    Dervieux T; Wessels JA; van der Straaten T; Penrod N; Moore JH; Guchelaar HJ; Kremer JM
    Pharmacogenet Genomics; 2009 Dec; 19(12):935-44. PubMed ID: 19858780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methotrexate-induced nausea and vomiting in adolescent and young adult patients.
    Patil P; Parker RA; Rawcliffe C; Olaleye A; Moore S; Daly N; Sen D; Ioannou Y
    Clin Rheumatol; 2014 Mar; 33(3):403-7. PubMed ID: 24108504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Utilization of Subcutaneous Methotrexate in Rheumatoid Arthritis Patients After Failure or Intolerance to Oral Methotrexate: A Multicenter Cohort Study.
    Branco JC; Barcelos A; de Araújo FP; Sequeira G; Cunha I; Patto JV; Oliveira M; Mateus MP; Couto M; Nero P; Pinto P; Monteiro P; Castelão W; Félix J; Ferreira D; Almeida J; Silva MJ
    Adv Ther; 2016 Jan; 33(1):46-57. PubMed ID: 26724937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The association between reduced folate carrier-1 gene 80G/A polymorphism and methotrexate efficacy or methotrexate related-toxicity in rheumatoid arthritis: A meta-analysis.
    Li X; Hu M; Li W; Gu L; Chen M; Ding H; Vanarsa K; Du Y
    Int Immunopharmacol; 2016 Sep; 38():8-15. PubMed ID: 27233001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic risk factors for drug-induced liver injury in rheumatoid arthritis patients using low-dose methotrexate.
    Dávila-Fajardo CL; Swen JJ; Cabeza Barrera J; Guchelaar HJ
    Pharmacogenomics; 2013 Jan; 14(1):63-73. PubMed ID: 23252949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The presence of HLA-DR B1 shared motif does not influence cyclophosphamide and methotrexate cytotoxicity in rheumatoid arthritis patients.
    Lacki JK; Wassmuth R; Korczowska I; Mackiewicz S; Muller W
    J Investig Allergol Clin Immunol; 2000; 10(4):235-41. PubMed ID: 11039841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral Methotrexate in split dose weekly versus oral or parenteral Methotrexate once weekly in Rheumatoid Arthritis: a short-term study.
    Dhaon P; Das SK; Srivastava R; Agarwal G; Asthana A
    Int J Rheum Dis; 2018 May; 21(5):1010-1017. PubMed ID: 27455886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methotrexate intolerance in the treatment of rheumatoid arthritis (RA): effect of adding caffeine to the management regimen.
    Malaviya AN
    Clin Rheumatol; 2017 Feb; 36(2):279-285. PubMed ID: 27596742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.